EC Number |
Disease |
PubMed ID |
Title of Publication |
Category |
Confidence Level |
---|
2.1.3.1 | Carcinoma |
28270654 |
A Proposed Physiopathological Pathway to Hyperammonemic Encephalopathy in a Non-Cirrhotic Patient with Fibrolamellar Hepatocellular Carcinoma without Ornithine Transcarbamylase (OTC) Mutation. |
causal interaction therapeutic application unassigned |
3 1 0 |
2.1.3.1 | Carcinoma, Ehrlich Tumor |
6508821 |
Binding of radiolabeled N-(phosphonacetyl)-L-aspartate to aspartate transcarbamylase from Ehrlich ascites tumor cells. |
diagnostic usage ongoing research unassigned |
3 1 0 |
2.1.3.1 | methylmalonyl-coa carboxytransferase deficiency |
33279518 |
Development of Gene Therapy Vectors: Remaining Challenges. |
causal interaction therapeutic application unassigned |
1 4 0 |
2.1.3.1 | Neoplasms |
6508821 |
Binding of radiolabeled N-(phosphonacetyl)-L-aspartate to aspartate transcarbamylase from Ehrlich ascites tumor cells. |
diagnostic usage ongoing research unassigned |
3 1 0 |
2.1.3.1 | Urea Cycle Disorders, Inborn |
28270654 |
A Proposed Physiopathological Pathway to Hyperammonemic Encephalopathy in a Non-Cirrhotic Patient with Fibrolamellar Hepatocellular Carcinoma without Ornithine Transcarbamylase (OTC) Mutation. |
causal interaction therapeutic application unassigned |
3 1 0 |